Literature DB >> 14691989

Maternal midtrimester free beta-HCG and AFP serum levels in spontaneous singleton pregnancies complicated by gestational diabetes mellitus, pregnancy-induced hypertension or obstetric cholestasis.

R Räty1, L Anttila, A Virtanen, P Koskinen, P Laitinen, P Mörsky, A Tiitinen, H Martikainen, U Ekblad.   

Abstract

OBJECTIVES: The present study aims at finding out whether a connection exists between altered serum free beta-hCG and/or alpha-fetoprotein (AFP) levels and the manifestation of specific pregnancy complications [i.e. gestational diabetes mellitus (GDM), pregnancy induced hypertension (PIH) or intrahepatic cholestasis of pregnancy (ICP)].
METHODS: We compared free beta-hCG and AFP multiples of median (MoM) values in singleton pregnancies. The study population consisted of 117 pregnancies with GDM, 107 with PIH and 24 with ICP. The control group consisted of 1148 singleton pregnancies without any pregnancy complications. All were spontaneously conceived.
RESULTS: In the group with GDM, both the free beta-hCG (0.72 MoM) and AFP MoM values (0.93) were significantly lower than in controls (beta-hCG 0.97 MoM, p = 0.0063 and AFP 1.01 MoM, p = 0.01). No statistically significant differences in the marker levels were observed between the ICP pregnancies and the control group.
CONCLUSIONS: GDM has an impact on maternal midtrimester free beta-hCG and AFP levels and may change the DS screening result. Copyright 2003 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14691989     DOI: 10.1002/pd.751

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  4 in total

Review 1.  Intrahepatic cholestasis of pregnancy.

Authors:  Victoria Geenes; Catherine Williamson
Journal:  World J Gastroenterol       Date:  2009-05-07       Impact factor: 5.742

2.  Maternal serum biomarkers for risk assessment in gestational diabetes. A potential universal screening test to predict GDM status.

Authors:  Srinivasa R Nagalla; Caryn K Snyder; John E Michaels; Mary J Laughlin; Charles T Roberts; Madhuri Balaji; V Balaji; V Seshiah; Paturi V Rao
Journal:  Indian J Endocrinol Metab       Date:  2015 Jan-Feb

3.  Diagnostic accuracy of maternal serum multiple marker screening for early detection of gestational diabetes mellitus in the absence of a gold standard test.

Authors:  Maedeh Amini; Anoshirvan Kazemnejad; Farid Zayeri; Ali Montazeri; Aliakbar Rasekhi; Azam Amirian; Nourossadat Kariman
Journal:  BMC Pregnancy Childbirth       Date:  2020-06-26       Impact factor: 3.007

4.  Could first- and second-trimester biochemical markers for Down syndrome have a role in predicting intrahepatic cholestasis of pregnancy?

Authors:  Ahter Tanay Tayyar; Ahmet Tayyar; Tolga Atakul; Cigdem Abide Yayla; Cetin Kilicci; Ahmet Eser; Resul Karakus; Dilsat Herkiloglu; Cevat Rifat Cundubey; Mehmet Tayyar
Journal:  Arch Med Sci       Date:  2017-09-05       Impact factor: 3.318

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.